Myasthenia Gravis Treatment Market Segments, Driver, Restraints, And Trends

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

LONDON, GREATER LONDON, UK, July 8, 2024 /EINPresswire.com/ — The myasthenia gravis treatment market is projected to grow from $1.42 billion in 2023 to $1.54 billion in 2024 at a CAGR of 8.1%. The market is anticipated to reach $2.05 billion by 2028, driven by advancements in biologics and monoclonal antibodies, genetic and precision medicine, and emerging immune modulators.

Surge in Prevalence of Myasthenia Gravis Drives Market Growth
The surge in the prevalence of myasthenia gravis is a significant factor contributing to the growth of the myasthenia gravis treatment market. Myasthenia gravis is an autoimmune neuromuscular disease causing fatigue and weakness in the skeletal muscles. The increased prevalence of this condition boosts the demand for effective treatments. According to the National Organization for Rare Disorders, the prevalence of autoimmune myasthenia gravis in the US is estimated to be 14–40 per 100,000 individuals. Similarly, a study by Kermanshah University of Medical Sciences and University Putra Malaysia estimated the global prevalence at 12.4 people per 100,000.

Explore comprehensive insights into the myasthenia gravis treatment market with a detailed sample report:

Key Players and Market Trends
Major companies operating in the myasthenia gravis treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Baxter International Inc., and Biogen Idec. These companies are focusing on strategic partnerships to enhance patient-centered care. For instance, in April 2023, Huma Therapeutics partnered with UCB S.A. to provide digital health solutions for managing myasthenia gravis.

Trends in the Market
The forecast period is expected to see trends such as digital therapeutics, collaborative research initiatives, patient-centric approaches, real-world evidence utilization, and long-term safety monitoring. These trends aim to improve the quality of care and patient outcomes in the treatment of myasthenia gravis.

Segments:
• By Treatment: Medication, Surgery, Other Treatments
• By Medication Type: Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, Other Medication Types
• By End-Use: Hospitals, Clinics, Other End-Uses
Geographical Insights: North America Leading the Market

North America was the largest region in the myasthenia gravis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities.

Explore the report store to make a direct purchase of the report

Myasthenia Gravis Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Myasthenia Gravis Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on myasthenia gravis treatment market size, myasthenia gravis treatment market drivers and trends, myasthenia gravis treatment market major players, competitors’ revenues, market positioning, and market growth across geographies. The myasthenia gravis treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

Urinary Stone Treatment Devices And Equipment Global Market Report 2024

Fertility Treatments Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn